National Jewish Health

Immunology

Sending children with food allergies to school can be stressful

As summer winds down, parents and children are preparing for the start of the school year, but for children with food allergies, heading to school for the first time can come with significant stress and anxiety. When a child ...

Diseases, Conditions, Syndromes

Gene panel predicts course of cystic fibrosis

Researchers at National Jewish Health have identified 10 immune-related genes whose activity during a respiratory infection predict the long-term prognosis for cystic fibrosis patients better than conventional measures. Five ...

Immunology

Researchers discover new source of skin defects in eczema

Researchers at National Jewish Health have discovered a cause of the dry, inflamed and itchy skin that plagues eczema patients. A team led by Donald Leung, MD, Ph.D., has shown that an immune system skewed toward allergy ...

Health

New exercises help athletes manage dangerous breathing disorder

A novel set of breathing techniques developed at National Jewish Health help athletes overcome vocal cord dysfunction and improve performance during high-intensity exercise. Vocal cord dysfunction, now also referred to as ...

Diseases, Conditions, Syndromes

Mepolizumab helps patients with refractory Churg-Strauss syndrome

Mepolizumab, an anti-IL5 monoclonal antibody, demonstrated significant benefits for patients with refractory cases of the rare autoimmune disease Churg-Strauss Syndrome, according to research at National Jewish Health and ...

Immunology

Trigger for autoimmune disease identified

Researchers at National Jewish Health have identified a trigger for autoimmune diseases such as lupus, Crohn's disease and multiple sclerosis. The findings, published in the April 2017 issue of Journal of Clinical Investigation, ...

Diseases, Conditions, Syndromes

Exacerbations of COPD accelerate lung-function loss

Exacerbations of chronic obstructive pulmonary disease (COPD) accelerate the loss of lung function especially among patients with mild disease, according to researchers at National Jewish Health and other institutions. Barry ...

page 2 from 6